CHEMOTHERAPY OF PENILE CARCINOMA
Authors:
prim. MUDr. Michaela Matoušková
Authors place of work:
Urocentrum Praha
Published in the journal:
Urol List 2005; 3(4): 18-20
Summary
Penil carcinoma belongs with its low incidence of less than 0,5% of all male oncological diseases to rare tumours. Phimosis and insufficient hygiene are important risk factors. On the contrary the circumcision in the childhood has proved a protection effect. We prove spinocellular carcinoma in more than 95% of patients. Stage I and II are usually curable by both surgical ablation or organ preserving methods (brachytherapy, laserablation etc). Patients´ survival is dependent on nodal affection (N+). Patients without clinically positive nodal affection with infiltrating tumours (> T2), high tumour grading and proved vascular invasion benefit from lymphadenectomy. Lymphadenectomy of palpable nodes usually followed after at least 4-6 weeks of antibiotic therapy. The role of chemotherapy both adjuvant and nonadjuvant, eventually primary in generalized diseases, is nowadays evaluated in prospective clinical studies.
KEY WORDS:
penile carcinoma, chemotherapy, spinocellular carcinoma, circumcision
Zdroje
1. Berrino F, Capocaccia R, Coleman MP et al.: Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003; 14 (Suppl5): 150-153.
2. Wieland U, Jurk S, Weissenborn T et al. Erythroplasia of Queyrat: Coinfection with cutaneous cancerogenic human papillomavirus type 8 and genital papillomaviruses in carcinoma in situ. J Invest Dermatol 2000; 115: 396-401.
3. Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin N Am 1992; 19: 247-256.
4. Coral DA, Sella A, Pettaway CA et al. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 1998; 160: 1170-1174.
5. Hass GP, Blumenstein BA, Gagliano RG et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999; 161: 1823-1825.
6. Hussein AM, Benedetto P, Sridhar KS. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas. Cancer 1990; 65: 433-438.
7. Shammas FV, Ous S, Fossa S. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992; 147: 630-632.
8. Fisher HA, Barada JH, Horton J et al. Neoadjuvant therapy with cisplatin and 5-fluorouracil for stage III squamous cell carcinoma of the penis. J Urol 1990; 146: 653.
9. Pizzocaro G, Piva L, Nicolai N. Treatment of lymfatic metastases of squamous cell carcinoma of the penis: experience at the National Tumor Institute of Milan. Arch Ital Urol Androl 1996; 68: 169-172.
10. Joerger M, Warzinek T, Klaeser B et al. Major tumor regression after paclitaxel and carboplatin polychemotherapy in patient with advanced penile cancer. Urology 2004; 63: 778-780.
11. Skeel RT, Huang J, Manola J et al. A phase II study of 13-cis retinoic acid plus interferon aplha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893). Cancer Invest 2003; 21: 41-46.
Štítky
Paediatric urologist UrologyČlánok vyšiel v časopise
Urological Journal
2005 Číslo 4
Najčítanejšie v tomto čísle
- MALE GENITAL LYMPHEDEMA
- LYMPHODRAINAGE OF PENIS
- PROBLEMS OF NODAL AFFECTION IN PENILE CARCINOMA
- SURGICAL TREATMENT OF PENILE CARCINOMA LOCALIZED IN THE ORGAN